Post-Operative Nausea and Vomiting Market Analysis By Type of treatment (pharmacological and non-pharmacological treatments), By Type of surgery (laparoscopic procedures, gynecological surgeries, and ear, nose, and throat surgeries), By End-users (hospitals, ambulatory surgical centers, and clinics. Hospitals) & Forecast 2024-2035
- PUBLISHED ON
- 4/14/2023
- NO OF PAGES
- 263
- CATEGORY
- Healthcare & Life Sciences
Post-operative nausea and vomiting (PONV) is a common complication that occurs after surgery and can significantly affect patient outcomes and satisfaction. PONV can be caused by a variety of factors, including anesthesia, surgical trauma, and patient-related factors. The treatment of PONV typically involves the use of antiemetic drugs, such as ondansetron and dexamethasone.
The global post-operative nausea and vomiting market has been growing steadily over the past few years and is expected to continue to do so in the coming years. The growth of the post-operative nausea and vomiting market can be attributed to several factors, including the increasing prevalence of PONV, the growing demand for effective and safe antiemetic drugs, and the availability of new and innovative products.
Furthermore, the development of new treatment guidelines and protocols for PONV management is expected to drive market growth in the coming years. Additionally, the increasing adoption of multimodal approaches to PONV management, which involve the use of multiple drugs and non-pharmacologic interventions, is expected to fuel market growth.
However, the post-operative nausea and vomiting market still faces some challenges, including the high cost of some antiemetic drugs, the limited availability of some drugs in certain regions, and the risk of adverse effects associated with the use of some drugs.
Overall, the post-operative nausea and vomiting market is expected to continue to grow in the coming years as the demand for effective and safe antiemetic drugs continues to rise. However, the industry will need to address some of the challenges facing the market in order to maintain its growth and meet the needs of patients and healthcare professionals.
Segment Overview
Post-operative nausea and vomiting (PONV) is a common complication after surgery, affecting up to 80% of patients. The PONV market can be segmented based on various factors such as:
1. Type of treatment: The PONV market can be segmented into pharmacological and non-pharmacological treatments. Pharmacological treatments include antiemetic drugs such as serotonin receptor antagonists, dopamine receptor antagonists, and corticosteroids. Non-pharmacological treatments include acupressure, acupuncture, and electroacupuncture.
2. Type of surgery: The PONV market can also be segmented based on the type of surgery. Patients undergoing certain surgeries such as laparoscopic procedures, gynecological surgeries, and ear, nose, and throat surgeries are at a higher risk of developing PONV. Therefore, the demand for PONV treatments is higher in these patient populations.
3. Geography: The PONV market can also be segmented based on geography. The prevalence of PONV varies across different regions, and so does the demand for PONV treatments. For example, the demand for PONV treatments may be higher in countries where laparoscopic surgeries are more common.
4. End-users: The PONV market can also be segmented based on end-users such as hospitals, ambulatory surgical centers, and clinics. Hospitals are the primary end-users of PONV treatments, as the majority of surgeries are performed in hospitals.
Overall, the PONV market is expected to grow in the coming years due to the increasing number of surgical procedures being performed and the growing awareness among healthcare professionals about the importance of PONV management.
Geographical Overview
Post-operative nausea and vomiting (PONV) is a common complication that occurs after surgery. The market for PONV management includes a variety of drugs and therapies that are used to prevent or treat PONV. The geography of this market can be divided into several regions based on the prevalence of PONV and the availability of healthcare resources.
1. North America is currently the largest market for PONV management. This is due to the high prevalence of PONV in the region, as well as the availability of advanced healthcare facilities and a well-established pharmaceutical industry. The United States is the largest market within North America, followed by Canada.
2. Europe is also a significant market for PONV management. Like North America, Europe has a high prevalence of PONV, and the region has a well-established healthcare infrastructure. Countries such as Germany, the United Kingdom, and France are the largest markets in Europe.
3. The Asia Pacific region is expected to experience the highest growth in the PONV management market in the coming years. This is due to the increasing prevalence of PONV in the region, as well as the growing demand for advanced healthcare facilities. China, Japan, and India are the largest markets in the Asia Pacific region.
4. Latin America and the Middle East and Africa are smaller markets for PONV management, but they are expected to experience moderate growth in the coming years. Factors such as increasing healthcare expenditure and growing awareness about PONV management are expected to drive market growth in these regions.
Overall, the global market for PONV management is expected to grow in the coming years due to factors such as increasing prevalence of PONV, growing demand for advanced healthcare facilities, and the development of new drugs and therapies for PONV management.
COVID Impact
The COVID-19 pandemic has impacted the Post-operative Nausea and Vomiting (PONV) market in several ways. PONV is a common complication after surgery and can occur in up to 80% of patients.
One of the significant impacts of the pandemic on the PONV market has been the decrease in the number of elective surgeries. Due to the pandemic, many hospitals and healthcare facilities have postponed or canceled elective surgeries to prioritize COVID-19 patients. This has resulted in a decreased demand for PONV products.
Moreover, the pandemic has also led to disruptions in the supply chain of PONV products. The disruptions have been caused by various factors, including factory closures, travel restrictions, and transportation issues. This has led to shortages and increased prices of PONV products.
On the other hand, the pandemic has also led to an increased focus on infection prevention in hospitals and healthcare facilities. This has resulted in an increased use of PONV products, as they can help prevent infections caused by vomiting and aspiration.
Additionally, the pandemic has also led to an increased focus on patient comfort and recovery. PONV can be a significant source of discomfort for patients after surgery, and the use of PONV products can help alleviate this discomfort.
In conclusion, the COVID-19 pandemic has had mixed impacts on the PONV market, with decreased demand due to the decrease in elective surgeries and disruptions in the supply chain, but also increased use due to the focus on infection prevention and patient comfort.
Competitive Analysis
The post-operative nausea and vomiting (PONV) market is a niche segment of the broader antiemetic market, and is dominated by a few key players.
1. Merck & Co., Inc.
2. Pfizer Inc.
3. GlaxoSmithKline plc.
4. Sanofi S.A.
5. Helsinn Healthcare S.A.
6. Eisai Co., Ltd.
7. Teva Pharmaceutical Industries Ltd.
8. F. Hoffmann-La Roche AG
9. Acacia Pharma Group plc.
10. Acrotech Biopharma LLC
These companies are constantly engaged in R&D activities to develop new and improved formulations of PONV treatments, as well as expanding their distribution networks to reach a larger customer base.
Factors that are likely to impact the competitive landscape of the PONV market include:
1. Efficacy: Companies that are able to offer PONV treatments that are more effective in preventing and treating nausea and vomiting are likely to have an advantage in the market.
2. Safety: Companies that are able to develop PONV treatments with a favorable safety profile are likely to have an edge in the market.
3. Regulatory landscape: Companies that are able to navigate the complex regulatory environment and obtain necessary approvals in a timely manner are likely to have an advantage.
4. Pricing: Companies that are able to offer PONV treatments at competitive prices while maintaining high quality standards are likely to be successful in the market.
5. Marketing and branding: Companies that are able to effectively market and brand their PONV treatments to healthcare professionals and patients are likely to have a larger market share.
6. Strategic partnerships and collaborations: Companies that are able to form strategic partnerships and collaborations with other players in the market are likely to have an advantage in terms of market share and distribution networks.
Overall, the PONV market is expected to continue to grow as the number of surgical procedures increases and awareness of the condition grows. With a few key players dominating the market, competition is likely to remain relatively stable, but the market may see new players entering as technological advancements and regulatory changes occur.
Historic Year: 2016-2022
Forecast: 2024-2035
Quality Assurance Process
- We Market Research’s Quality Assurance program strives to deliver superior value to our clients.
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
- Project kickoff meeting with client
- Conduct frequent client communications
- Form project steering committee
- Assign a senior SR executive as QA Executive
- Conduct internal editorial & quality reviews of project deliverables
- Certify project staff in SR methodologies & standards
- Monitor client satisfaction
- Monitor realized value post-project
Case Study- Automotive Sector
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached Straits Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
Solution
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
Market Estimates and Forecast
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Case Study- ICT Sector
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2028.
}})
Select a license type that suits your business needs
US $4250
Only Four Thousand Two Hundred Fifty US dollar
- 1 User access
- 15% Additional Free Customization
- Free Unlimited post-sale support
- 100% Service Guarantee until achievement of ROI
US $5250
Only Five Thousand Two Hundred Fifty US dollar
- 5 Users access
- 25% Additional Free Customization
- Access Report summaries for Free
- Guaranteed service
- Dedicated Account Manager
- Discount of 20% on next purchase
- Get personalized market brief from Lead Author
- Printing of Report permitted
- Discount of 20% on next purchase
- 100% Service Guarantee until achievement of ROI
US $6250
Only Six Thousand Two Hundred Fifty US dollar
- Unlimited User Access
- 30% Additional Free Customization
- Exclusive Previews to latest or upcoming reports
- Discount of 30% on next purchase
- 100% Service Guarantee until achievement of ROI